top of page
  • Writer's pictureMuvon

The leadership from MUVON Therapeutics AG will be attending JP Morgan Healthcare week in Jan 2023

The leadership from MUVON Therapeutics AG will be attending JP Morgan the premier life sciences investment conference in San Francisco from Jan 9 to Jan 12 to meet potential investors and collaboration partners for accelerating the development of our novel cell therapy for skeletal muscle regeneration.


Chief Executive Officer Deana Mohr, Chief Business Officer Steve Kappenthuler and Regulatory Affairs Leader Milena Brankov look forward to meeting with you, exchanging ideas and forging new connections around our scheduled meetings.

Please reach out to info@muvon-therapeutics.ch to schedule a meeting.

327 views0 comments

Comments


bottom of page